SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

GUIDOBONI, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 292
AS - Asia 94
EU - Europa 91
Totale 477
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 292
CN - Cina 39
IT - Italia 27
SG - Singapore 27
UA - Ucraina 25
ID - Indonesia 20
DE - Germania 11
GB - Regno Unito 11
FI - Finlandia 6
FR - Francia 6
TR - Turchia 6
SE - Svezia 4
IN - India 2
NL - Olanda 1
Totale 477
Salva come PNG Salva come JPEG
Città #
Woodbridge 37
Fairfield 36
Houston 33
Jacksonville 26
Jakarta 20
Singapore 19
Dearborn 16
Ashburn 15
Shanghai 13
Seattle 11
Cambridge 10
Chandler 10
Ferrara 10
Wilmington 9
Nanjing 6
Boardman 5
Izmir 5
Princeton 5
San Diego 5
Ann Arbor 4
Nanchang 4
Beijing 3
Brescia 2
Brookline 2
Ferrara di Monte Baldo 2
Forlì 2
Hebei 2
Lappeenranta 2
London 2
Monza 2
New York 2
Shenyang 2
Amsterdam 1
Bremen 1
Chiswick 1
Crevalcore 1
Frankfurt am Main 1
Fuzhou 1
Guangzhou 1
Hefei 1
Kunming 1
Milan 1
Ningbo 1
Rome 1
San Mateo 1
Springfield 1
Taiyuan 1
Tappahannock 1
Tianjin 1
Xuzhou 1
Zhengzhou 1
Totale 341
Salva come PNG Salva come JPEG
Nome #
Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis 112
The long-term prognostic impact of sentinel lymph node biopsy in patients with primary cutaneous melanoma: a prospective study with 10-year follow-up 80
Prognostic value of microsatellite instability and intratumor activated cytotoxic lymphocytes in colon cancer 64
Effect of vaccination with autologous tumor-loaded dendritic cells on intratumoral regulatory T cells in metastatic melanoma patients 64
Retinoic acid inhibits the proliferative response induced by CD40 activation and interleukin-4 in mantle cell lymphoma. 53
Stability Program in Dendritic Cell Vaccines: A “Real-World” Experience in the Immuno-Gene Therapy Factory of Romagna Cancer Center 13
Anti-PD1 antibodies in patients aged ≥ 75 years with metastatic melanoma: A retrospective multicentre study 10
Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated BRAF-Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial 10
Comparative efficacy and safety of targeted therapies for BRAF-mutant unresectable or metastatic melanoma: Results from a systematic literature review and a network meta-analysis 9
ILLUMINATE 301: A randomized phase III study of tilsotolimod in combination with ipilimumab compared with ipilimumab alone in patients with advanced melanoma following progression on or after anti-PD-1 therapy 8
Primary Analysis and 4-Year Follow-Up of the Phase III NIBIT-M2 Trial in Melanoma Patients With Brain Metastases 8
Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma 8
Efficacy of ipilimumab plus nivolumab or ipilimumab plus fotemustine vs fotemustine in patients with melanoma metastatic to the brain: Primary analysis of the phase III NIBIT-M2 trial 7
Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial 7
First-line, Fixed-Duration Nivolumab plus Ipilimumab Followed by Nivolumab in Clinically Diverse Patient Populations With Unresectable Stage III or IV Melanoma: CheckMate 401 6
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma 6
Neoadjuvant plus adjuvant combined or sequenced vemurafenib, cobimetinib and atezolizumab in patients with high-risk, resectable BRAF-mutated and wild-type melanoma: NEO-TIM, a phase II randomized non-comparative study 6
First report of efficacy and safety from the phase II study SECOMBIT (SEquential COMBo Immuno and Targeted Therapy study) 6
Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: Final data 5
Melanoma metastasis mimicking gastric cancer: a challenge that starts from diagnosis 5
Radiotherapy and High-Dose Interleukin-2: Clinical and Immunological Results of a Proof of Principle Study in Metastatic Melanoma and Renal Cell Carcinoma 5
Retrospective Chart Review of Dabrafenib Plus Trametinib in Patients with Metastatic BRAF V600-Mutant Melanoma Treated in the Individual Patient Program (DESCRIBE Italy) 5
Cancer Bio-Immunotherapy in Siena": Twelfth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 9-11, 2014 5
Malignant Pleural Mesothelioma: State-of-the-Art on Current Therapies and Promises for the Future 5
Functional up-regulation of human leukocyte antigen class I antigens expression by 5-aza-2'-deoxycytidine in cutaneous melanoma: immunotherapeutic implications 4
Outcomes in patients with BRAFV600–mutated melanoma and brain metastases at baseline treated with dabrafenib plus trametinib 3
Unexpected High Response Rate to Traditional Therapy after Dendritic Cell-Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis 3
Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: clinical and immunological evidence from three patient cases 3
Combined and sequential expression of p53, Rb, Ras and Bcl-2 in bronchial preneoplastic lesions 2
Dabrafenib-trametinib combination in 'field-practice': an Italian experience 2
Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial 2
Isolated bone marrow manifestation of HIV-associated Hodgkin lymphoma 2
Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study 2
Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases 2
IDIOTYPIC VACCIN 2
Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study 2
Correspondence re: Samowitz et al., Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol. Biomark. Prev., 10 : 917-923, 2001 2
Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience 2
Complementary vaccination protocol with dendritic cells pulsed with autologous tumour lysate in patients with resected stage III or IV melanoma: protocol for a phase II randomised trial (ACDC Adjuvant Trial). 2
Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: A multicenter prospective trial 2
Activation of infiltrating cytotoxic T lymphocytes and lymphoma cell apoptotic rates in gastric MALT lymphomas - Differences between high-grade and low-grade cases 2
Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study 2
Melanoma vaccines in development 1
Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy 1
Latent membrane protein 1 deletion mutants accumulate in Reed-Sternberg cells of human immunodeficiency virus-related Hodgkin's lymphoma 1
Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab 1
Dendritic cell-based vaccine in advanced melanoma: update of clinical outcome 1
Rituximab in patients with mucosal-associated lymphold tissue-type lymphoma of the ocular adnexa 1
Vaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and/or preleukapheresis IFN-alpha in patients with metastatic melanoma: a randomised "proof-of-principle" phase II study 1
Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma 1
High serum levels of soluble CD40-L in patients with undifferentiated nasopharyngeal carcinoma: pathogenic and clinical relevance 1
Retinoic acid inhibits IL-6-dependent but not constitutive STAT3 activation in Epstein-Barr virus-immortalized B lymphocytes 1
High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability 1
Association between Helicobacter pylori infection and MALT-type lymphoma of the ocular adnexa: clinical and therapeutic implications 1
Retinoic acid stabilizes p27(Kip1) in EBV-immortalized lymphoblastoid B cell lines through enhanced proteasome-dependent degradation of the p45(Skp2) and Cks1 proteins 1
Epigenetic remodelling of DNA in cancer 1
Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4(+)CD25(++)Foxp3(+) regulatory T-cells in advanced melanoma patients 1
Ipilimumab in advanced melanoma: reports of long-lasting responses 1
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma 1
Skewing effect of sulprostone on dendritic cell maturation compared with dinoprostone 1
Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: evaluation of biomarkers of immunologic and therapeutic response 1
IL-17/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemia 1
Italian nivolumab Expanded Access Programme in melanoma adjuvant setting: patient outcomes and safety profile 1
CTLA-4 gene variant -1661A>G may predict the onset of endocrine adverse events in metastatic melanoma patients treated with ipilimumab 1
IGKV3 Proteins as Candidate "Off-the-Shelf" Vaccines for Kappa-Light Chain-Restricted B-Cell Non-Hodgkin Lymphomas 1
MicroRNAs and dendritic cell-based vaccination in melanoma patients 1
Appropriate use of tumour biomarkers for treatment with innovative drugs: A retrospective study 1
Undifferentiated nasopharyngeal carcinoma from a nonendemic area: Protective role of HLA allele products presenting conserved EBV epitopes 1
Liver Metastases from Melanoma: Hepatic Intra-Arterial Chemotherapy. A Retrospective Study 1
Chlamydia infection and lymphomas: Association beyond ocular adnexal lymphomas highlighted by multiple detection methods 1
Interleukin-10 and interleukin-18 promoter polymorphisms in an Italian cohort of patients with undifferentiated carcinoma of nasopharyngeal type 1
Near-Complete Response to Osimertinib for Advanced Non-Small-Cell Lung Cancer in a Pretreated Patient Bearing Rare Compound Exon 20 Mutation (S768I + V774M): A Case Report 1
Infectious agents in mucosa-associated lymphoid tissue-type lymphomas: Pathogenic role and therapeutic perspectives 1
Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas 1
Increased frequency of acute reactions to iodinated contrast media in cancer patients treated with anti-CTLA-4 immunomodulatory antibodies. 1
Totale 581
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.059
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 28
Totale 6.087
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202099 14 3 1 15 10 14 12 9 6 11 2 2
2020/202153 7 5 2 6 0 7 0 8 0 7 9 2
2021/202257 4 4 1 2 1 2 1 9 3 4 3 23
2022/202351 6 4 1 4 9 4 1 3 8 1 8 2
2023/2024197 3 6 3 2 0 50 0 51 0 4 19 59
2024/202517 17 0 0 0 0 0 0 0 0 0 0 0
Totale 581